Elysium, the company bringing scientific advances as consumer products to address healthcare and aging, has raised $40M in Series C funding from investors that include General Catalyst, Western Technology Investment, Morningside Venture Capital, Breyer Capital, Mayo Clinic Ventures, and GISEV Family Office. Founded by Dan Alminana, Eric Marcotulli, and Leonard Pershing Guarente in 2014, Elysium has now raised a total of $71.2M in reported equity funding.
The AlleyWatch audience is driving progress and innovation on a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including sponsoring a piece like this, which will be read by the vast majority of key influencers in the entrepreneurial universe. Find out more here.